Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 796.26

-0.6%

Jan 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (878)	10/7/2003 8:53:13 PM
From: Miljenko Zuanic	of 3559

ZUDIJA = <<I take it that is Croatian for "remarkably good at looking after their own interests, (the *******s)" ?>> WORSE! From DJ: (Regeneron said it hasn't yet found the most effective dosage and indicated that higher doses may demonstrate a greater efficacy."If I were in their shoes, I would do another Phase II trial to make sure they've got their dose nailed down,"Mr. King said.) I thought that you do this in PI? Figure MTD and MEF (bio-market, in this case CRP). Also, develop formulation that is stable (RT) and with desired drug concentration. They wasted +12 months, but they HOOKED Novartis, nonetheless. :) Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next